Read more: PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for up to 12 years
Read more: PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for up to 12 years
Read the rest here: Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
Read this article: Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome
Link: Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2
Read the original: Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease
Original post: Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
Read the original: Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes
View post: Acasti Announces Year-End 2024 Financial Results, Provides Business Update
Continue reading here: Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences
Read more from the original source: Starton Therapeutics Announces 100% Partial Response or Better in Multiple Myeloma Patients in Interim, Top-line Data from STAR-LLD Phase 1b Clinical...
Recent Comments